A fter activation by antigen-presenting cells, naive, antigenspecific CD4
1 T cells differentiate into effector T cells. Two decades ago, Coffman and Mosman first discovered the heterogeneity of effector T cells, which were named as Th1 or Th2 cells.
1 Th1 and Th2 cells are differentially induced and are involved in immunity against intracellular and extracellular pathogens, respectively, as well as immunopathologies such as autoimmunity and allergy. The Th1/ Th2 dichotomy dominated the field of immune regulation until about 4 years ago when IL-17-expressing T cells were proposed to be a third lineage of helper T cells. 2, 3 In addition to these so-called Th17 cells, additional T-cell subsets were also discovered or studied, including In this issue, experts offer timely summaries of the development and function of novel T-cells subsets. Here I discuss several issues that are raised in these reviews and provide a personal perspective.
Subset or lineage:
The heterogeneous phenotypes of Th cells can be termed as states, subsets and lineages. In my view, the term 'lineage' should be defined stringently, i.e., meaning an independent, genetically controlled cell differentiation pathway. For example, it is widely accepted that Th1, Th2, Th17 and Treg cells are of different lineages. They are generated independently during immune responses. Also 'master' transcription factors have been found to mediate their differentiation. Small non-coding RNAs may also emerge as key players in this process, as discussed by Wei and Pei in this issue. 4 Wan reviews the differentiation of Treg cells 5 and Xu et al. reviews the differentiation of Th17 cells. 6 Tfh cells may add to Th list with the discovery of Bcl6 as its key transcriptional regulator, which is covered by Yu et al. 7 and Nurieva et al. 8 Cells that are differentiated into the same pathway may also exhibit heterogeneity. This can be stochastic or the result of different environmental cues. While the immune system is powerful against foreign pathogens, unbalanced or unwanted immune responses may result in autoimmunity. Leung et al. discuss the interplays of pathogenic Th1 and Th17 cells and anti-inflammatory Treg cells in autoimmunity. 9 Enhanced Tfh function is also associated with certain systemic autoimmune diseases. 8 It is important to consider strategies to shift the equation into protection from pathogenesis in patients.
In summary, this series of reviews highlights the recent developments in T-cell subset research. They present the current understanding of the regulation and function of T cells in immunity and immune diseases, and may guide best practice in basic, translational and clinical research.
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